Alexia Perouse

Biography

 Alexia Perouse is doubly qualified in Neurosciences and Management of Enterprises and has worked more than 20 years in the development of public or private innovative companies. She started her career in the biotechnology field working as an analyst for Chiron Vaccines and Parteurop Développement before joining the sector of Private Equity in 1999 at Sofinnova Partners then at Omnes Capital in 2005. As a partner, Alexia was in charge of the venture capital portfolio (representing € 330M). Specifically, she has developed the medical device (« medtech ») and connected health portfolios. She has led investments in over ten start-ups (Gecko Biomedical, EyeTechCare…) and played an active governing role as Director. She also pursued several merger and acquisitions such as Biolipox – Orexo, Mutabilis, Pharma Omnium International, Fovea Pharmaceuticals / Sanofi-Aventis, Circulite Inc / Heartware Inc., and several IPO’s such as Eos Imaging (EOSI), Stentys (STNT), SpineGuard (ALSGD), SuperSonic Image (SSI), Pixium Vision (PIX), and Cellnovo (CNV). Since December 2015, she has been the CEO & Managing Partner at iBionext: a French company specialized in the support of medical innovative and disruptive technologies from creation to growth. Alexia Perouse also sits on the board of directors of SuperSonic Imagine: an innovative, international company specialized in medical imaging.

Research Interest

 Neurosciences and Management